查看購物車
  • English
  • Japanese
封面
市場調查報告書
商品編碼
1988393

管腔成形術市場：2026-2032年全球市場預測（依產品類型、手術方法、最終用戶、通路、適應症和年齡層分類）

Canaloplasty Market by Product Type, Technique, End User, Distribution Channel, Indication, Age Group - Global Forecast 2026-2032
出版日期: | 出版商: 360iResearch | 英文 189 Pages | 商品交期: 最快1-2個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

預計到 2025 年，導管成形術市場價值將達到 5.9484 億美元，到 2026 年將成長至 6.4248 億美元，到 2032 年將達到 9.8748 億美元，年複合成長率為 7.50%。

主要市場統計數據
基準年 2025 5.9484億美元
預計年份：2026年 6.4248億美元
預測年份 2032 9.8748億美元
複合年成長率 (%) 7.50%

從臨床和商業性角度概述了管腔成形術，將其定位為一個程序生態系統，它透過設備、技術和臨床環境重塑了青光眼治療的交付方式。

在手術技術創新和臨床醫師日益深入的理解推動下，小梁成形術正逐漸成為青光眼治療新典範的核心。該領域結合了精密的顯微外科技術和基於器械的治療方法，旨在恢復房水生理性流出，同時減少對長期藥物治療的依賴。因此，臨床醫生和醫療系統越來越認知到，小梁成形術是傳統濾過手術和現代微創手術之間的橋樑。

器材工程的平行進步、微創技術的引入以及醫療保健服務體系的重新設計，正在重新定義管腔成形術的臨床實踐和商業化。

近年來，技術進步、流程標準化和相關人員的協作共同創造了新的機遇，帶來了變革性的改變，重新定義了管腔成形術的實施和商業化方式。微導管設計的創新提高了管腔內導航和擴張的準確性，而手術器械包中擴大配備了最佳化的黏彈性物質，這些物質能夠提供可預測的組織行為，並促進可重複的治療效果。除了這些產品層面的進步之外，人們越來越傾向於採用「內路」（Ab Interno）技術，這是一種微創技術，它透過減少手術創傷、加快康復速度和降低資源消耗，擴大了適用人群。

評估近期美國關稅調整如何重塑 Kanaloplastics 利害關係人的供應鏈選擇、製造策略和商業性動態。

美國2025年實施的關稅政策，對服務於眼科醫療設備製造商和經銷商的全球供應鏈產生了連鎖反應，帶來了新的限制和獎勵。針對特定醫療設備和組件進口關稅的調整，迫使製造商加快重新評估籌資策略，重新評估區域製造地，並實現供應商多元化，以降低成本風險。因此，這些變化正在影響分銷商的定價策略，以及原始設備製造商（OEM）分銷商和增值轉售商之間的談判動態。這些經銷商必須在維持服務水準的同時，應對利潤率壓力。

策略性細分洞察揭示了產品類型、外科手術程序、最終用戶環境、通路、臨床適應症和年齡層如何相互作用，從而決定臨床採用和商業性重點。

透過詳細的細分觀點，可以揭示哪些產品類型和手術方法會影響臨床醫生的偏好和購買行為。微導管的產品創新提高了管腔內導航和輸送精度，而整合式手術套件的普及則簡化了術中工作流程並減少了設定差異。黏彈性劑在管腔成形術中發揮至關重要的作用，而黏性黏彈性劑和分散性黏彈性劑之間的差異具有重要的臨床意義。黏性黏彈性劑有助於在一次手術中完成管腔擴張和取出，而分散性配方可能在複雜的解剖結構中提供更好的組織保護，這會影響臨床醫生根據具體病例情況的選擇。

區域比較評估，以確定報銷制度、臨床基礎設施和分銷生態系統對管腔成形術的推廣和供應商策略影響最大的區域。

區域趨勢差異顯著，投資、臨床教育和供應鏈最佳化等因素影響哪些地區取得最佳成果。在美洲，成熟的報銷體系和完善的門診手術基礎設施支援微創管成形術的快速普及；然而，該地區也面臨著集中的成本壓力，促使採購趨勢轉向捆綁式解決方案和經濟實惠的耗材。歐洲、中東和非洲（EMEA）地區的情況則較為複雜。一些歐洲市場擁有先進的監管路徑和廣泛的手術應用，而中東和非洲則湧現出許多新興的優秀醫療中心，這些中心優先開展旨在提升當地醫療能力的培訓和技術轉移計畫。在這些地區，與當地分銷商建立合作關係以及投資於臨床醫生教育對於擴大手術量至關重要。

競爭與夥伴關係模式是卡納洛塑膠公司發展壯大的關鍵，這些公司包括成熟的多元化投資組合公司、創新專家和通路合作夥伴。

競爭格局呈現出兩極化的局面：既有擁有廣泛眼科產品線的成熟醫療設備製造商，也有專注於微創青光眼手術技術的專業創新企業。老字型大小企業利用臨床試驗網路、手術訓練計畫和一體化服務模式，維護高價值基本客群，並將自身定位為提供全面手術解決方案的供應商。同時，專業醫療設備公司則專注於差異化的導管設計、一次性手術包或新型黏彈劑，從而獲得臨床實踐的支持，並在早期用戶中確立高階地位。

為了加快推廣應用，製造商和通路合作夥伴應專注於以下幾個方面：收集證據、開發適應性強的商業模式以及設計具有韌性的供應鏈。

產業領導者應優先考慮以下三個面向：產生臨床證據、增強供應鏈韌性以及開發差異化的商業模式，以維持發展動能。投資於前瞻性註冊研究和合作性真實世界證據（RWE）計畫將有助於檢驗針對不同適應症的治療效果，包括原發性開放性青光眼以及新生血管性和色素性等疑難續發性青光眼。這些努力應與有針對性的臨床醫生教育舉措相結合，重點強調外路和內路手術方法之間的細微操作差異，以及選擇黏彈性物質（黏性劑和分散性劑）的實際意義。

本研究結合了主要調查方法（說明對臨床醫生和相關人員的訪談）和次要研究方法（例如對監管和臨床文獻的審查以及多軸分割分析）。

本分析的調查方法結合了定性和定量方法，旨在深入了解小梁成形術的發展趨勢。主要調查包括對青光眼外科醫生、門診手術中心管理人員、醫院採購負責人和銷售合作夥伴進行結構化訪談，以收集第一線人員對手術方案選擇、器械偏好和服務期望的觀點。此外，我們還進行了補充調查，整合了監管指南、手術規範框架和已發表的臨床文獻，以全面檢驗臨床應用的促進因素，並識別不同器械之間的比較特徵。

強調證據、培訓和營運韌性的策略整合，對於將管腔成形術的臨床創新轉化為永續的臨床應用至關重要。

總之，管腔成形術處於醫療設備創新、外科技術發展和醫療服務模式變革的交匯點，所有這些因素共同對製造商、分銷商和醫療機構產生了重大的策略影響。在此背景下，能夠將可靠的臨床證據、臨床醫生培訓和靈活的銷售管道相結合，同時保持供應鏈的適應性並應對不斷變化的貿易政策和區域監管複雜性的企業將擁有顯著優勢。產品差異化，尤其是在微導管性能、手術器械包設計和黏彈性方面，將繼續影響臨床醫生的選擇和手術技術的應用。

目錄

第1章：序言

第2章：調查方法

  • 調查設計
  • 研究框架
  • 市場規模預測
  • 數據三角測量
  • 調查結果
  • 調查的前提
  • 研究限制

第3章執行摘要

  • 首席主管觀點
  • 市場規模和成長趨勢
  • 2025年市佔率分析
  • FPNV定位矩陣，2025
  • 新的商機
  • 下一代經營模式
  • 產業藍圖

第4章 市場概覽

  • 產業生態系與價值鏈分析
  • 波特五力分析
  • PESTEL 分析
  • 市場展望
  • 上市策略

第5章 市場洞察

  • 消費者洞察與終端用戶觀點
  • 消費者體驗基準
  • 機會映射
  • 分銷通路分析
  • 價格趨勢分析
  • 監理合規和標準框架
  • ESG與永續性分析
  • 中斷和風險情景
  • 投資報酬率和成本效益分析

第6章：美國關稅的累積影響，2025年

第7章：人工智慧的累積影響，2025年

第8章：管腔成形術市場：依產品類型分類

  • 微導管
  • 手術包
  • 黏彈性劑
    • 內聚黏彈性劑
    • 可分散黏彈性劑

第9章：根管成形術市場：依手術方法分類

  • 外眼入路
  • 內眼方法
    • 微創方法

第10章：導管成形術市場：依最終用戶分類

  • 門診手術中心
    • 合作夥伴設施
    • 獨立設施
  • 醫院
    • 私立醫院
    • 公立醫院
  • 眼科診所
    • 連鎖診所
    • 獨立診所

第11章：導管成形術市場：依通路分類

  • 直銷
  • 透過分銷商銷售
    • OEM分銷商
    • 增值轉售商

第12章 耳蝸成形術市場：依適應症分類

  • 原發性開放性青光眼
  • 續發性青光眼
    • 新生血管性青光眼
    • 色素性青光眼

第13章：耳道成形術市場：依年齡層別分類

  • 成人
  • 老年人
  • 兒童

第14章：導管成形術市場：依地區分類

  • 北美洲和南美洲
    • 北美洲
    • 拉丁美洲
  • 歐洲、中東和非洲
    • 歐洲
    • 中東
    • 非洲
  • 亞太地區

第15章：管腔成形術市場：依組別分類

  • ASEAN
  • GCC
  • EU
  • BRICS
  • G7
  • NATO

第16章：管腔成形術市場：依國家分類

  • 美國
  • 加拿大
  • 墨西哥
  • 巴西
  • 英國
  • 德國
  • 法國
  • 俄羅斯
  • 義大利
  • 西班牙
  • 中國
  • 印度
  • 日本
  • 澳洲
  • 韓國

第17章 美國：管腔成形術市場

第18章 中國：管腔成形術市場

第19章 競爭情勢

  • 市場集中度分析，2025年
    • 濃度比（CR）
    • 赫芬達爾-赫希曼指數 (HHI)
  • 近期趨勢及影響分析，2025 年
  • 2025年產品系列分析
  • 基準分析，2025 年
  • Alcon Inc.
  • Beaver-Visitec International
  • Glaukos Corporation
  • InnFocus Inc.
  • iSTAR Medical SA
  • Ivantis Inc.
  • Johnson & Johnson Vision
  • New World Medical Inc.
  • Santen Pharmaceutical Co. Ltd.
  • Sight Sciences Inc.
  • SOLX Inc.
Product Code: MRR-8958E923A70E

The Canaloplasty Market was valued at USD 594.84 million in 2025 and is projected to grow to USD 642.48 million in 2026, with a CAGR of 7.50%, reaching USD 987.48 million by 2032.

KEY MARKET STATISTICS
Base Year [2025] USD 594.84 million
Estimated Year [2026] USD 642.48 million
Forecast Year [2032] USD 987.48 million
CAGR (%) 7.50%

A clinical and commercial overview that positions canaloplasty as a procedural ecosystem reshaping glaucoma care delivery across devices, techniques, and care settings

Canaloplasty has emerged as a focal point in the evolving treatment paradigm for glaucoma, driven by procedural innovation and expanding clinician familiarity. The field blends refined micro-surgical techniques with device-enabled approaches that aim to restore physiologic aqueous outflow while reducing reliance on chronic pharmacotherapy. As a result, clinicians and health systems are increasingly exploring canaloplasty as a bridge between traditional filtration surgeries and modern microinvasive options.

This introduction frames canaloplasty not simply as a procedure, but as an ecosystem comprising specialized instruments such as microcatheters, integrated surgical kits, and supporting viscoelastic agents designed to facilitate trabecular and Schlemm's canal interventions. The technique portfolio spans Ab Externo approaches to Ab Interno microinvasive procedures, and the treatment is being adopted across care settings from ambulatory surgical centers to hospital operating theaters and dedicated ophthalmology clinics. Understanding these dynamics is essential for stakeholders seeking to prioritize product roadmaps, refine commercial models, and align clinical evidence generation with payer and provider expectations.

How concurrent advances in device engineering, microinvasive technique adoption, and care delivery redesign are converging to redefine canaloplasty practice and commercialization

Recent years have witnessed transformative shifts that are redefining how canaloplasty is practiced and commercialized, with technological refinement, procedural standardization, and stakeholder alignment converging to create new opportunities. Innovation in microcatheter design has improved navigation and dilation of the canal, while surgical kits are increasingly bundled with optimized viscoelastic agents that deliver predictable tissue behavior and facilitate reproducible outcomes. These product-level advances are complemented by a shift toward Ab Interno microinvasive approaches that reduce surgical trauma and expand the candidate pool by enabling faster recovery and lower resource utilization.

Concurrently, payer perceptions and hospital credentialing practices are evolving. Real-world evidence demonstrating the potential to reduce medication burden and improve intraocular pressure stability has supported more streamlined coverage pathways in certain jurisdictions. Additionally, care delivery is shifting toward ambulatory surgical centers and specialized ophthalmology clinics that can perform high volumes of minimally invasive procedures. These centers are investing in training, device inventories, and protocol standardization, accelerating diffusion and creating a competitive environment in which suppliers must demonstrate both clinical value and operational efficiency.

Assessment of how recent United States tariff adjustments have reshaped supply chain choices, manufacturing strategies, and commercial dynamics for canaloplasty stakeholders

The tariffs implemented by the United States in 2025 introduced a new set of constraints and incentives that ripple across global supply chains serving ophthalmic device manufacturers and distributors. Tariff adjustments on certain medical devices and component imports have compelled manufacturers to reassess sourcing strategies, reconsider regional manufacturing footprints, and accelerate supplier diversification to mitigate cost exposure. In turn, these shifts have influenced distributor pricing strategies and the negotiation dynamics between Original Equipment Distributors and value added resellers, who must manage margin pressure while preserving service levels.

Beyond procurement, the tariff environment affected investment timing and capital allocation decisions. Some established manufacturers accelerated local assembly or sought contractual toll-manufacturing arrangements within tariff-favored jurisdictions to preserve competitiveness. Conversely, smaller specialized device firms faced tighter windows to absorb incremental cost without compromising commercial momentum, prompting some to prioritize high-value product lines and strategic partnerships. As a result, clinicians and institutional purchasers observed subtle shifts in product availability, promotional support, and post-market service offerings, reinforcing the importance of resilient supply chain design and adaptive commercial models in the face of trade policy volatility.

Strategic segmentation insights revealing how product types, procedural techniques, end-user settings, distribution routes, clinical indications, and age cohorts jointly determine clinical adoption and commercial focus

A granular segmentation lens reveals which product categories and procedural approaches are shaping clinician preference and purchasing behavior. Product innovations in microcatheters have improved canal navigation and delivery precision, while the proliferation of integrated surgical kits streamlines intraoperative workflows and reduces setup variability. Viscoelastic agents play a crucial role in canaloplasty procedures, and distinctions between cohesive viscoelastics and dispersive viscoelastics matter clinically; cohesive agents facilitate canal expansion and removal in a single sweep, whereas dispersive formulations may confer more tissue protection in complex anatomy, influencing clinician choice depending on the case profile.

Technique segmentation further differentiates market needs. Ab Externo approaches remain relevant for certain anatomies and surgeon preferences, but the rapid ascent of Ab Interno techniques-especially those leveraging microinvasive approaches-has broadened adoption among anterior segment surgeons who favor reduced invasiveness and faster postoperative recovery. End-user segmentation underlines where procedural adoption surfaces in the healthcare delivery chain: ambulatory surgical centers, both affiliated and independent, are key venues for high-throughput minimally invasive procedures; hospitals, whether private or public, continue to support more complex cases and training; and ophthalmology clinics, including chain networks and independent practices, are increasingly integrating procedural offerings alongside clinical management. Distribution channel dynamics are similarly nuanced. Direct sales remain critical for high-touch, capital-intensive accounts that require training and clinical support, whereas distributor sales, routed through original equipment distributors or value added resellers, enable broader geographic reach and flexible inventory management. Clinical indications also shape clinical pathways and procurement priorities. Primary open angle glaucoma remains the predominant indication driving procedural volume, while secondary glaucomas, such as neovascular and pigmentary glaucoma, create demand for tailored approaches and adjunctive products. Finally, age group segmentation underscores distinct clinical considerations across adult, geriatric, and pediatric patients, with geriatric cohorts presenting comorbidity patterns that influence perioperative planning and device selection.

Comparative regional evaluation that clarifies where reimbursement frameworks, clinical infrastructure, and distribution ecosystems most strongly influence canaloplasty adoption and supplier strategy

Regional dynamics vary significantly and influence where investment, clinical education, and supply chain optimization yield the greatest returns. In the Americas, mature reimbursement frameworks and established ambulatory surgical infrastructure support rapid adoption of minimally invasive canaloplasty options, yet this region also faces concentrated cost pressures that shift purchasing toward bundled solutions and cost-effective consumables. Europe, Middle East & Africa presents a heterogeneous landscape: select European markets exhibit advanced regulatory pathways and broad procedural uptake, while pockets across the Middle East and Africa show emerging centers of excellence that prioritize training and technology transfer programs to build local capacity. In these geographies, partnerships with local distributors and investment in clinician education are pivotal to scaling procedural volumes.

Asia-Pacific spans highly developed markets with sophisticated hospital systems and rapidly expanding ambulatory networks, as well as emerging economies where access to specialty devices is improving. In well-resourced APAC markets, there is a premium on innovation and evidence generation to support differentiated product positioning, whereas in growth markets, affordability and supply chain reliability drive procurement. Across regions, regulatory nuances, reimbursement mechanisms, and the distribution ecosystem shape timing and pathways for clinical adoption. As a consequence, a region-aware commercial playbook that aligns product configurations, training investments, and distributor engagement strategies is essential to capture opportunity while managing operational risk.

Competitive dynamics and partnership models that distinguish established multi-portfolio firms, specialized innovators, and channel partners driving adoption and scale in canaloplasty

The competitive landscape is characterized by a mix of established medical device firms with broad ophthalmic portfolios and focused innovators that specialize in microinvasive glaucoma surgery technologies. Established players leverage clinical trial networks, surgeon training programs, and integrated service models to protect high-value accounts and to position comprehensive procedural solutions. Focused device firms, on the other hand, concentrate on differentiated catheter designs, single-use surgical kits, or novel viscoelastic chemistries to gain clinical traction and to command premium positioning among early adopters.

Complementing these manufacturers, contract manufacturers and high-quality component suppliers play an instrumental role in bringing complex microdevice designs to market quickly and at scale. Similarly, distributor partners, whether original equipment distributors or value added resellers, contribute localized market knowledge, aftermarket service, and channel flexibility. Strategic collaborations between technology owners and distribution partners are increasingly common, enabling rapid geographic expansion while reducing direct operating burden. Finally, service-oriented entrants that bundle training, outcomes tracking, and procedural support are differentiating by promising faster adoption cycles and better real-world outcomes documentation, thereby appealing to health systems prioritizing clinical governance and quality assurance.

Actionable strategic priorities for manufacturers and channel partners focused on evidence generation, adaptive commercial models, and resilient supply chain design to accelerate adoption

Industry leaders should prioritize a combination of clinical evidence generation, supply chain resilience, and differentiated commercial models to sustain momentum. Investing in prospective registries and collaborative real-world evidence programs will help validate outcomes across diverse indications, including primary open angle glaucoma and challenging secondary glaucomas such as neovascular and pigmentary etiologies. These efforts should be synchronized with targeted clinician education initiatives that emphasize technique nuances between Ab Externo and Ab Interno approaches and the practical implications of choosing cohesive versus dispersive viscoelastic agents.

On the commercial front, organizations would benefit from tailoring engagement models to end-user segmentation. High-touch accounts in hospital systems and affiliated ambulatory surgical centers often require direct sales engagement, hands-on training, and bundled service arrangements, whereas broader geographic coverage can be achieved through distributor sales that leverage original equipment distributors and value added resellers. Operationally, companies should diversify manufacturing and component sourcing to mitigate tariff and trade risks, while exploring nearshoring or regional assembly strategies that preserve margin and delivery reliability. Finally, aligning product roadmaps with age-specific clinical needs and with the procedural preferences of high-volume surgeons will strengthen reimbursement dialogues and differentiate offerings in competitive tenders.

Methodological framework describing primary clinician and stakeholder interviews complemented by secondary regulatory and clinical literature reviews with multi-axis segmentation analysis

The research methodology underpinning this analysis combined qualitative and quantitative approaches to construct a robust understanding of canaloplasty dynamics. Primary research included structured interviews with practicing glaucoma surgeons, ambulatory surgical center administrators, hospital procurement officers, and distributor partners to capture firsthand perspectives on procedure selection, device preferences, and service expectations. These interviews were complemented by secondary research that synthesized regulatory guidance, procedural coding frameworks, and published clinical literature to triangulate clinical adoption drivers and to verify comparative device attributes.

Analytical frameworks used in the study emphasized segmentation across product types, techniques, end-user settings, distribution channels, clinical indications, and patient age groups to surface actionable insights. Supply chain and policy impact analysis incorporated trade policy review, procurement practices, and supplier capability assessments. Where applicable, sensitivity checks and cross-validation against clinician feedback ensured that conclusions reflect operational realities and the practical constraints encountered by adopters in diverse geographies.

A strategic synthesis emphasizing the imperative for evidence, training, and operational resilience to convert clinical innovation in canaloplasty into sustained clinical adoption

In summary, canaloplasty represents an intersection of device innovation, procedural evolution, and shifting care delivery models that together create substantial strategic implications for manufacturers, distributors, and clinical institutions. The landscape favors organizations that can combine robust clinical evidence, clinician training, and flexible commercial channels while maintaining supply chain adaptability in the face of trade policy changes and regional regulatory complexity. Attention to product differentiation-particularly in microcatheter performance, surgical kit design, and viscoelastic properties-will continue to influence clinician preference and procedural uptake.

Moving forward, stakeholders that invest in partnership models, targeted real-world evidence programs, and regionally optimized go-to-market strategies will be best positioned to translate clinical promise into enduring adoption. Coordinated efforts that align innovation, reimbursement engagement, and operational resilience will be essential to meet the nuanced needs of diverse patient cohorts and care settings.

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Definition
  • 1.3. Market Segmentation & Coverage
  • 1.4. Years Considered for the Study
  • 1.5. Currency Considered for the Study
  • 1.6. Language Considered for the Study
  • 1.7. Key Stakeholders

2. Research Methodology

  • 2.1. Introduction
  • 2.2. Research Design
    • 2.2.1. Primary Research
    • 2.2.2. Secondary Research
  • 2.3. Research Framework
    • 2.3.1. Qualitative Analysis
    • 2.3.2. Quantitative Analysis
  • 2.4. Market Size Estimation
    • 2.4.1. Top-Down Approach
    • 2.4.2. Bottom-Up Approach
  • 2.5. Data Triangulation
  • 2.6. Research Outcomes
  • 2.7. Research Assumptions
  • 2.8. Research Limitations

3. Executive Summary

  • 3.1. Introduction
  • 3.2. CXO Perspective
  • 3.3. Market Size & Growth Trends
  • 3.4. Market Share Analysis, 2025
  • 3.5. FPNV Positioning Matrix, 2025
  • 3.6. New Revenue Opportunities
  • 3.7. Next-Generation Business Models
  • 3.8. Industry Roadmap

4. Market Overview

  • 4.1. Introduction
  • 4.2. Industry Ecosystem & Value Chain Analysis
    • 4.2.1. Supply-Side Analysis
    • 4.2.2. Demand-Side Analysis
    • 4.2.3. Stakeholder Analysis
  • 4.3. Porter's Five Forces Analysis
  • 4.4. PESTLE Analysis
  • 4.5. Market Outlook
    • 4.5.1. Near-Term Market Outlook (0-2 Years)
    • 4.5.2. Medium-Term Market Outlook (3-5 Years)
    • 4.5.3. Long-Term Market Outlook (5-10 Years)
  • 4.6. Go-to-Market Strategy

5. Market Insights

  • 5.1. Consumer Insights & End-User Perspective
  • 5.2. Consumer Experience Benchmarking
  • 5.3. Opportunity Mapping
  • 5.4. Distribution Channel Analysis
  • 5.5. Pricing Trend Analysis
  • 5.6. Regulatory Compliance & Standards Framework
  • 5.7. ESG & Sustainability Analysis
  • 5.8. Disruption & Risk Scenarios
  • 5.9. Return on Investment & Cost-Benefit Analysis

6. Cumulative Impact of United States Tariffs 2025

7. Cumulative Impact of Artificial Intelligence 2025

8. Canaloplasty Market, by Product Type

  • 8.1. Microcatheters
  • 8.2. Surgical Kits
  • 8.3. Viscoelastic Agents
    • 8.3.1. Cohesive Viscoelastic
    • 8.3.2. Dispersive Viscoelastic

9. Canaloplasty Market, by Technique

  • 9.1. Ab Externo
  • 9.2. Ab Interno
    • 9.2.1. Microinvasive Approach

10. Canaloplasty Market, by End User

  • 10.1. Ambulatory Surgical Centers
    • 10.1.1. Affiliated Centers
    • 10.1.2. Independent Centers
  • 10.2. Hospitals
    • 10.2.1. Private Hospitals
    • 10.2.2. Public Hospitals
  • 10.3. Ophthalmology Clinics
    • 10.3.1. Chain Clinics
    • 10.3.2. Independent Clinics

11. Canaloplasty Market, by Distribution Channel

  • 11.1. Direct Sales
  • 11.2. Distributor Sales
    • 11.2.1. Original Equipment Distributors
    • 11.2.2. Value Added Resellers

12. Canaloplasty Market, by Indication

  • 12.1. Primary Open Angle Glaucoma
  • 12.2. Secondary Glaucoma
    • 12.2.1. Neovascular Glaucoma
    • 12.2.2. Pigmentary Glaucoma

13. Canaloplasty Market, by Age Group

  • 13.1. Adult
  • 13.2. Geriatric
  • 13.3. Pediatric

14. Canaloplasty Market, by Region

  • 14.1. Americas
    • 14.1.1. North America
    • 14.1.2. Latin America
  • 14.2. Europe, Middle East & Africa
    • 14.2.1. Europe
    • 14.2.2. Middle East
    • 14.2.3. Africa
  • 14.3. Asia-Pacific

15. Canaloplasty Market, by Group

  • 15.1. ASEAN
  • 15.2. GCC
  • 15.3. European Union
  • 15.4. BRICS
  • 15.5. G7
  • 15.6. NATO

16. Canaloplasty Market, by Country

  • 16.1. United States
  • 16.2. Canada
  • 16.3. Mexico
  • 16.4. Brazil
  • 16.5. United Kingdom
  • 16.6. Germany
  • 16.7. France
  • 16.8. Russia
  • 16.9. Italy
  • 16.10. Spain
  • 16.11. China
  • 16.12. India
  • 16.13. Japan
  • 16.14. Australia
  • 16.15. South Korea

17. United States Canaloplasty Market

18. China Canaloplasty Market

19. Competitive Landscape

  • 19.1. Market Concentration Analysis, 2025
    • 19.1.1. Concentration Ratio (CR)
    • 19.1.2. Herfindahl Hirschman Index (HHI)
  • 19.2. Recent Developments & Impact Analysis, 2025
  • 19.3. Product Portfolio Analysis, 2025
  • 19.4. Benchmarking Analysis, 2025
  • 19.5. Alcon Inc.
  • 19.6. Beaver-Visitec International
  • 19.7. Glaukos Corporation
  • 19.8. InnFocus Inc.
  • 19.9. iSTAR Medical SA
  • 19.10. Ivantis Inc.
  • 19.11. Johnson & Johnson Vision
  • 19.12. New World Medical Inc.
  • 19.13. Santen Pharmaceutical Co. Ltd.
  • 19.14. Sight Sciences Inc.
  • 19.15. SOLX Inc.

LIST OF FIGURES

  • FIGURE 1. GLOBAL CANALOPLASTY MARKET SIZE, 2018-2032 (USD MILLION)
  • FIGURE 2. GLOBAL CANALOPLASTY MARKET SHARE, BY KEY PLAYER, 2025
  • FIGURE 3. GLOBAL CANALOPLASTY MARKET, FPNV POSITIONING MATRIX, 2025
  • FIGURE 4. GLOBAL CANALOPLASTY MARKET SIZE, BY PRODUCT TYPE, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 5. GLOBAL CANALOPLASTY MARKET SIZE, BY TECHNIQUE, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 6. GLOBAL CANALOPLASTY MARKET SIZE, BY END USER, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 7. GLOBAL CANALOPLASTY MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 8. GLOBAL CANALOPLASTY MARKET SIZE, BY INDICATION, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 9. GLOBAL CANALOPLASTY MARKET SIZE, BY AGE GROUP, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 10. GLOBAL CANALOPLASTY MARKET SIZE, BY REGION, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 11. GLOBAL CANALOPLASTY MARKET SIZE, BY GROUP, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 12. GLOBAL CANALOPLASTY MARKET SIZE, BY COUNTRY, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 13. UNITED STATES CANALOPLASTY MARKET SIZE, 2018-2032 (USD MILLION)
  • FIGURE 14. CHINA CANALOPLASTY MARKET SIZE, 2018-2032 (USD MILLION)

LIST OF TABLES

  • TABLE 1. GLOBAL CANALOPLASTY MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 2. GLOBAL CANALOPLASTY MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 3. GLOBAL CANALOPLASTY MARKET SIZE, BY MICROCATHETERS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 4. GLOBAL CANALOPLASTY MARKET SIZE, BY MICROCATHETERS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 5. GLOBAL CANALOPLASTY MARKET SIZE, BY MICROCATHETERS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 6. GLOBAL CANALOPLASTY MARKET SIZE, BY SURGICAL KITS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 7. GLOBAL CANALOPLASTY MARKET SIZE, BY SURGICAL KITS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 8. GLOBAL CANALOPLASTY MARKET SIZE, BY SURGICAL KITS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 9. GLOBAL CANALOPLASTY MARKET SIZE, BY VISCOELASTIC AGENTS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 10. GLOBAL CANALOPLASTY MARKET SIZE, BY VISCOELASTIC AGENTS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 11. GLOBAL CANALOPLASTY MARKET SIZE, BY VISCOELASTIC AGENTS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 12. GLOBAL CANALOPLASTY MARKET SIZE, BY VISCOELASTIC AGENTS, 2018-2032 (USD MILLION)
  • TABLE 13. GLOBAL CANALOPLASTY MARKET SIZE, BY COHESIVE VISCOELASTIC, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 14. GLOBAL CANALOPLASTY MARKET SIZE, BY COHESIVE VISCOELASTIC, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 15. GLOBAL CANALOPLASTY MARKET SIZE, BY COHESIVE VISCOELASTIC, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 16. GLOBAL CANALOPLASTY MARKET SIZE, BY DISPERSIVE VISCOELASTIC, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 17. GLOBAL CANALOPLASTY MARKET SIZE, BY DISPERSIVE VISCOELASTIC, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 18. GLOBAL CANALOPLASTY MARKET SIZE, BY DISPERSIVE VISCOELASTIC, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 19. GLOBAL CANALOPLASTY MARKET SIZE, BY TECHNIQUE, 2018-2032 (USD MILLION)
  • TABLE 20. GLOBAL CANALOPLASTY MARKET SIZE, BY AB EXTERNO, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 21. GLOBAL CANALOPLASTY MARKET SIZE, BY AB EXTERNO, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 22. GLOBAL CANALOPLASTY MARKET SIZE, BY AB EXTERNO, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 23. GLOBAL CANALOPLASTY MARKET SIZE, BY AB INTERNO, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 24. GLOBAL CANALOPLASTY MARKET SIZE, BY AB INTERNO, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 25. GLOBAL CANALOPLASTY MARKET SIZE, BY AB INTERNO, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 26. GLOBAL CANALOPLASTY MARKET SIZE, BY AB INTERNO, 2018-2032 (USD MILLION)
  • TABLE 27. GLOBAL CANALOPLASTY MARKET SIZE, BY MICROINVASIVE APPROACH, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 28. GLOBAL CANALOPLASTY MARKET SIZE, BY MICROINVASIVE APPROACH, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 29. GLOBAL CANALOPLASTY MARKET SIZE, BY MICROINVASIVE APPROACH, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 30. GLOBAL CANALOPLASTY MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 31. GLOBAL CANALOPLASTY MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 32. GLOBAL CANALOPLASTY MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 33. GLOBAL CANALOPLASTY MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 34. GLOBAL CANALOPLASTY MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, 2018-2032 (USD MILLION)
  • TABLE 35. GLOBAL CANALOPLASTY MARKET SIZE, BY AFFILIATED CENTERS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 36. GLOBAL CANALOPLASTY MARKET SIZE, BY AFFILIATED CENTERS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 37. GLOBAL CANALOPLASTY MARKET SIZE, BY AFFILIATED CENTERS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 38. GLOBAL CANALOPLASTY MARKET SIZE, BY INDEPENDENT CENTERS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 39. GLOBAL CANALOPLASTY MARKET SIZE, BY INDEPENDENT CENTERS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 40. GLOBAL CANALOPLASTY MARKET SIZE, BY INDEPENDENT CENTERS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 41. GLOBAL CANALOPLASTY MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 42. GLOBAL CANALOPLASTY MARKET SIZE, BY HOSPITALS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 43. GLOBAL CANALOPLASTY MARKET SIZE, BY HOSPITALS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 44. GLOBAL CANALOPLASTY MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
  • TABLE 45. GLOBAL CANALOPLASTY MARKET SIZE, BY PRIVATE HOSPITALS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 46. GLOBAL CANALOPLASTY MARKET SIZE, BY PRIVATE HOSPITALS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 47. GLOBAL CANALOPLASTY MARKET SIZE, BY PRIVATE HOSPITALS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 48. GLOBAL CANALOPLASTY MARKET SIZE, BY PUBLIC HOSPITALS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 49. GLOBAL CANALOPLASTY MARKET SIZE, BY PUBLIC HOSPITALS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 50. GLOBAL CANALOPLASTY MARKET SIZE, BY PUBLIC HOSPITALS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 51. GLOBAL CANALOPLASTY MARKET SIZE, BY OPHTHALMOLOGY CLINICS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 52. GLOBAL CANALOPLASTY MARKET SIZE, BY OPHTHALMOLOGY CLINICS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 53. GLOBAL CANALOPLASTY MARKET SIZE, BY OPHTHALMOLOGY CLINICS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 54. GLOBAL CANALOPLASTY MARKET SIZE, BY OPHTHALMOLOGY CLINICS, 2018-2032 (USD MILLION)
  • TABLE 55. GLOBAL CANALOPLASTY MARKET SIZE, BY CHAIN CLINICS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 56. GLOBAL CANALOPLASTY MARKET SIZE, BY CHAIN CLINICS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 57. GLOBAL CANALOPLASTY MARKET SIZE, BY CHAIN CLINICS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 58. GLOBAL CANALOPLASTY MARKET SIZE, BY INDEPENDENT CLINICS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 59. GLOBAL CANALOPLASTY MARKET SIZE, BY INDEPENDENT CLINICS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 60. GLOBAL CANALOPLASTY MARKET SIZE, BY INDEPENDENT CLINICS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 61. GLOBAL CANALOPLASTY MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 62. GLOBAL CANALOPLASTY MARKET SIZE, BY DIRECT SALES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 63. GLOBAL CANALOPLASTY MARKET SIZE, BY DIRECT SALES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 64. GLOBAL CANALOPLASTY MARKET SIZE, BY DIRECT SALES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 65. GLOBAL CANALOPLASTY MARKET SIZE, BY DISTRIBUTOR SALES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 66. GLOBAL CANALOPLASTY MARKET SIZE, BY DISTRIBUTOR SALES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 67. GLOBAL CANALOPLASTY MARKET SIZE, BY DISTRIBUTOR SALES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 68. GLOBAL CANALOPLASTY MARKET SIZE, BY DISTRIBUTOR SALES, 2018-2032 (USD MILLION)
  • TABLE 69. GLOBAL CANALOPLASTY MARKET SIZE, BY ORIGINAL EQUIPMENT DISTRIBUTORS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 70. GLOBAL CANALOPLASTY MARKET SIZE, BY ORIGINAL EQUIPMENT DISTRIBUTORS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 71. GLOBAL CANALOPLASTY MARKET SIZE, BY ORIGINAL EQUIPMENT DISTRIBUTORS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 72. GLOBAL CANALOPLASTY MARKET SIZE, BY VALUE ADDED RESELLERS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 73. GLOBAL CANALOPLASTY MARKET SIZE, BY VALUE ADDED RESELLERS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 74. GLOBAL CANALOPLASTY MARKET SIZE, BY VALUE ADDED RESELLERS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 75. GLOBAL CANALOPLASTY MARKET SIZE, BY INDICATION, 2018-2032 (USD MILLION)
  • TABLE 76. GLOBAL CANALOPLASTY MARKET SIZE, BY PRIMARY OPEN ANGLE GLAUCOMA, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 77. GLOBAL CANALOPLASTY MARKET SIZE, BY PRIMARY OPEN ANGLE GLAUCOMA, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 78. GLOBAL CANALOPLASTY MARKET SIZE, BY PRIMARY OPEN ANGLE GLAUCOMA, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 79. GLOBAL CANALOPLASTY MARKET SIZE, BY SECONDARY GLAUCOMA, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 80. GLOBAL CANALOPLASTY MARKET SIZE, BY SECONDARY GLAUCOMA, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 81. GLOBAL CANALOPLASTY MARKET SIZE, BY SECONDARY GLAUCOMA, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 82. GLOBAL CANALOPLASTY MARKET SIZE, BY SECONDARY GLAUCOMA, 2018-2032 (USD MILLION)
  • TABLE 83. GLOBAL CANALOPLASTY MARKET SIZE, BY NEOVASCULAR GLAUCOMA, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 84. GLOBAL CANALOPLASTY MARKET SIZE, BY NEOVASCULAR GLAUCOMA, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 85. GLOBAL CANALOPLASTY MARKET SIZE, BY NEOVASCULAR GLAUCOMA, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 86. GLOBAL CANALOPLASTY MARKET SIZE, BY PIGMENTARY GLAUCOMA, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 87. GLOBAL CANALOPLASTY MARKET SIZE, BY PIGMENTARY GLAUCOMA, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 88. GLOBAL CANALOPLASTY MARKET SIZE, BY PIGMENTARY GLAUCOMA, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 89. GLOBAL CANALOPLASTY MARKET SIZE, BY AGE GROUP, 2018-2032 (USD MILLION)
  • TABLE 90. GLOBAL CANALOPLASTY MARKET SIZE, BY ADULT, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 91. GLOBAL CANALOPLASTY MARKET SIZE, BY ADULT, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 92. GLOBAL CANALOPLASTY MARKET SIZE, BY ADULT, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 93. GLOBAL CANALOPLASTY MARKET SIZE, BY GERIATRIC, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 94. GLOBAL CANALOPLASTY MARKET SIZE, BY GERIATRIC, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 95. GLOBAL CANALOPLASTY MARKET SIZE, BY GERIATRIC, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 96. GLOBAL CANALOPLASTY MARKET SIZE, BY PEDIATRIC, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 97. GLOBAL CANALOPLASTY MARKET SIZE, BY PEDIATRIC, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 98. GLOBAL CANALOPLASTY MARKET SIZE, BY PEDIATRIC, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 99. GLOBAL CANALOPLASTY MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 100. AMERICAS CANALOPLASTY MARKET SIZE, BY SUBREGION, 2018-2032 (USD MILLION)
  • TABLE 101. AMERICAS CANALOPLASTY MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 102. AMERICAS CANALOPLASTY MARKET SIZE, BY VISCOELASTIC AGENTS, 2018-2032 (USD MILLION)
  • TABLE 103. AMERICAS CANALOPLASTY MARKET SIZE, BY TECHNIQUE, 2018-2032 (USD MILLION)
  • TABLE 104. AMERICAS CANALOPLASTY MARKET SIZE, BY AB INTERNO, 2018-2032 (USD MILLION)
  • TABLE 105. AMERICAS CANALOPLASTY MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 106. AMERICAS CANALOPLASTY MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, 2018-2032 (USD MILLION)
  • TABLE 107. AMERICAS CANALOPLASTY MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
  • TABLE 108. AMERICAS CANALOPLASTY MARKET SIZE, BY OPHTHALMOLOGY CLINICS, 2018-2032 (USD MILLION)
  • TABLE 109. AMERICAS CANALOPLASTY MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 110. AMERICAS CANALOPLASTY MARKET SIZE, BY DISTRIBUTOR SALES, 2018-2032 (USD MILLION)
  • TABLE 111. AMERICAS CANALOPLASTY MARKET SIZE, BY INDICATION, 2018-2032 (USD MILLION)
  • TABLE 112. AMERICAS CANALOPLASTY MARKET SIZE, BY SECONDARY GLAUCOMA, 2018-2032 (USD MILLION)
  • TABLE 113. AMERICAS CANALOPLASTY MARKET SIZE, BY AGE GROUP, 2018-2032 (USD MILLION)
  • TABLE 114. NORTH AMERICA CANALOPLASTY MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 115. NORTH AMERICA CANALOPLASTY MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 116. NORTH AMERICA CANALOPLASTY MARKET SIZE, BY VISCOELASTIC AGENTS, 2018-2032 (USD MILLION)
  • TABLE 117. NORTH AMERICA CANALOPLASTY MARKET SIZE, BY TECHNIQUE, 2018-2032 (USD MILLION)
  • TABLE 118. NORTH AMERICA CANALOPLASTY MARKET SIZE, BY AB INTERNO, 2018-2032 (USD MILLION)
  • TABLE 119. NORTH AMERICA CANALOPLASTY MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 120. NORTH AMERICA CANALOPLASTY MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, 2018-2032 (USD MILLION)
  • TABLE 121. NORTH AMERICA CANALOPLASTY MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
  • TABLE 122. NORTH AMERICA CANALOPLASTY MARKET SIZE, BY OPHTHALMOLOGY CLINICS, 2018-2032 (USD MILLION)
  • TABLE 123. NORTH AMERICA CANALOPLASTY MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 124. NORTH AMERICA CANALOPLASTY MARKET SIZE, BY DISTRIBUTOR SALES, 2018-2032 (USD MILLION)
  • TABLE 125. NORTH AMERICA CANALOPLASTY MARKET SIZE, BY INDICATION, 2018-2032 (USD MILLION)
  • TABLE 126. NORTH AMERICA CANALOPLASTY MARKET SIZE, BY SECONDARY GLAUCOMA, 2018-2032 (USD MILLION)
  • TABLE 127. NORTH AMERICA CANALOPLASTY MARKET SIZE, BY AGE GROUP, 2018-2032 (USD MILLION)
  • TABLE 128. LATIN AMERICA CANALOPLASTY MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 129. LATIN AMERICA CANALOPLASTY MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 130. LATIN AMERICA CANALOPLASTY MARKET SIZE, BY VISCOELASTIC AGENTS, 2018-2032 (USD MILLION)
  • TABLE 131. LATIN AMERICA CANALOPLASTY MARKET SIZE, BY TECHNIQUE, 2018-2032 (USD MILLION)
  • TABLE 132. LATIN AMERICA CANALOPLASTY MARKET SIZE, BY AB INTERNO, 2018-2032 (USD MILLION)
  • TABLE 133. LATIN AMERICA CANALOPLASTY MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 134. LATIN AMERICA CANALOPLASTY MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, 2018-2032 (USD MILLION)
  • TABLE 135. LATIN AMERICA CANALOPLASTY MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
  • TABLE 136. LATIN AMERICA CANALOPLASTY MARKET SIZE, BY OPHTHALMOLOGY CLINICS, 2018-2032 (USD MILLION)
  • TABLE 137. LATIN AMERICA CANALOPLASTY MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 138. LATIN AMERICA CANALOPLASTY MARKET SIZE, BY DISTRIBUTOR SALES, 2018-2032 (USD MILLION)
  • TABLE 139. LATIN AMERICA CANALOPLASTY MARKET SIZE, BY INDICATION, 2018-2032 (USD MILLION)
  • TABLE 140. LATIN AMERICA CANALOPLASTY MARKET SIZE, BY SECONDARY GLAUCOMA, 2018-2032 (USD MILLION)
  • TABLE 141. LATIN AMERICA CANALOPLASTY MARKET SIZE, BY AGE GROUP, 2018-2032 (USD MILLION)
  • TABLE 142. EUROPE, MIDDLE EAST & AFRICA CANALOPLASTY MARKET SIZE, BY SUBREGION, 2018-2032 (USD MILLION)
  • TABLE 143. EUROPE, MIDDLE EAST & AFRICA CANALOPLASTY MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 144. EUROPE, MIDDLE EAST & AFRICA CANALOPLASTY MARKET SIZE, BY VISCOELASTIC AGENTS, 2018-2032 (USD MILLION)
  • TABLE 145. EUROPE, MIDDLE EAST & AFRICA CANALOPLASTY MARKET SIZE, BY TECHNIQUE, 2018-2032 (USD MILLION)
  • TABLE 146. EUROPE, MIDDLE EAST & AFRICA CANALOPLASTY MARKET SIZE, BY AB INTERNO, 2018-2032 (USD MILLION)
  • TABLE 147. EUROPE, MIDDLE EAST & AFRICA CANALOPLASTY MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 148. EUROPE, MIDDLE EAST & AFRICA CANALOPLASTY MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, 2018-2032 (USD MILLION)
  • TABLE 149. EUROPE, MIDDLE EAST & AFRICA CANALOPLASTY MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
  • TABLE 150. EUROPE, MIDDLE EAST & AFRICA CANALOPLASTY MARKET SIZE, BY OPHTHALMOLOGY CLINICS, 2018-2032 (USD MILLION)
  • TABLE 151. EUROPE, MIDDLE EAST & AFRICA CANALOPLASTY MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 152. EUROPE, MIDDLE EAST & AFRICA CANALOPLASTY MARKET SIZE, BY DISTRIBUTOR SALES, 2018-2032 (USD MILLION)
  • TABLE 153. EUROPE, MIDDLE EAST & AFRICA CANALOPLASTY MARKET SIZE, BY INDICATION, 2018-2032 (USD MILLION)
  • TABLE 154. EUROPE, MIDDLE EAST & AFRICA CANALOPLASTY MARKET SIZE, BY SECONDARY GLAUCOMA, 2018-2032 (USD MILLION)
  • TABLE 155. EUROPE, MIDDLE EAST & AFRICA CANALOPLASTY MARKET SIZE, BY AGE GROUP, 2018-2032 (USD MILLION)
  • TABLE 156. EUROPE CANALOPLASTY MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 157. EUROPE CANALOPLASTY MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 158. EUROPE CANALOPLASTY MARKET SIZE, BY VISCOELASTIC AGENTS, 2018-2032 (USD MILLION)
  • TABLE 159. EUROPE CANALOPLASTY MARKET SIZE, BY TECHNIQUE, 2018-2032 (USD MILLION)
  • TABLE 160. EUROPE CANALOPLASTY MARKET SIZE, BY AB INTERNO, 2018-2032 (USD MILLION)
  • TABLE 161. EUROPE CANALOPLASTY MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 162. EUROPE CANALOPLASTY MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, 2018-2032 (USD MILLION)
  • TABLE 163. EUROPE CANALOPLASTY MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
  • TABLE 164. EUROPE CANALOPLASTY MARKET SIZE, BY OPHTHALMOLOGY CLINICS, 2018-2032 (USD MILLION)
  • TABLE 165. EUROPE CANALOPLASTY MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 166. EUROPE CANALOPLASTY MARKET SIZE, BY DISTRIBUTOR SALES, 2018-2032 (USD MILLION)
  • TABLE 167. EUROPE CANALOPLASTY MARKET SIZE, BY INDICATION, 2018-2032 (USD MILLION)
  • TABLE 168. EUROPE CANALOPLASTY MARKET SIZE, BY SECONDARY GLAUCOMA, 2018-2032 (USD MILLION)
  • TABLE 169. EUROPE CANALOPLASTY MARKET SIZE, BY AGE GROUP, 2018-2032 (USD MILLION)
  • TABLE 170. MIDDLE EAST CANALOPLASTY MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 171. MIDDLE EAST CANALOPLASTY MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 172. MIDDLE EAST CANALOPLASTY MARKET SIZE, BY VISCOELASTIC AGENTS, 2018-2032 (USD MILLION)
  • TABLE 173. MIDDLE EAST CANALOPLASTY MARKET SIZE, BY TECHNIQUE, 2018-2032 (USD MILLION)
  • TABLE 174. MIDDLE EAST CANALOPLASTY MARKET SIZE, BY AB INTERNO, 2018-2032 (USD MILLION)
  • TABLE 175. MIDDLE EAST CANALOPLASTY MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 176. MIDDLE EAST CANALOPLASTY MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, 2018-2032 (USD MILLION)
  • TABLE 177. MIDDLE EAST CANALOPLASTY MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
  • TABLE 178. MIDDLE EAST CANALOPLASTY MARKET SIZE, BY OPHTHALMOLOGY CLINICS, 2018-2032 (USD MILLION)
  • TABLE 179. MIDDLE EAST CANALOPLASTY MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 180. MIDDLE EAST CANALOPLASTY MARKET SIZE, BY DISTRIBUTOR SALES, 2018-2032 (USD MILLION)
  • TABLE 181. MIDDLE EAST CANALOPLASTY MARKET SIZE, BY INDICATION, 2018-2032 (USD MILLION)
  • TABLE 182. MIDDLE EAST CANALOPLASTY MARKET SIZE, BY SECONDARY GLAUCOMA, 2018-2032 (USD MILLION)
  • TABLE 183. MIDDLE EAST CANALOPLASTY MARKET SIZE, BY AGE GROUP, 2018-2032 (USD MILLION)
  • TABLE 184. AFRICA CANALOPLASTY MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 185. AFRICA CANALOPLASTY MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 186. AFRICA CANALOPLASTY MARKET SIZE, BY VISCOELASTIC AGENTS, 2018-2032 (USD MILLION)
  • TABLE 187. AFRICA CANALOPLASTY MARKET SIZE, BY TECHNIQUE, 2018-2032 (USD MILLION)
  • TABLE 188. AFRICA CANALOPLASTY MARKET SIZE, BY AB INTERNO, 2018-2032 (USD MILLION)
  • TABLE 189. AFRICA CANALOPLASTY MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 190. AFRICA CANALOPLASTY MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, 2018-2032 (USD MILLION)
  • TABLE 191. AFRICA CANALOPLASTY MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
  • TABLE 192. AFRICA CANALOPLASTY MARKET SIZE, BY OPHTHALMOLOGY CLINICS, 2018-2032 (USD MILLION)
  • TABLE 193. AFRICA CANALOPLASTY MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 194. AFRICA CANALOPLASTY MARKET SIZE, BY DISTRIBUTOR SALES, 2018-2032 (USD MILLION)
  • TABLE 195. AFRICA CANALOPLASTY MARKET SIZE, BY INDICATION, 2018-2032 (USD MILLION)
  • TABLE 196. AFRICA CANALOPLASTY MARKET SIZE, BY SECONDARY GLAUCOMA, 2018-2032 (USD MILLION)
  • TABLE 197. AFRICA CANALOPLASTY MARKET SIZE, BY AGE GROUP, 2018-2032 (USD MILLION)
  • TABLE 198. ASIA-PACIFIC CANALOPLASTY MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 199. ASIA-PACIFIC CANALOPLASTY MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 200. ASIA-PACIFIC CANALOPLASTY MARKET SIZE, BY VISCOELASTIC AGENTS, 2018-2032 (USD MILLION)
  • TABLE 201. ASIA-PACIFIC CANALOPLASTY MARKET SIZE, BY TECHNIQUE, 2018-2032 (USD MILLION)
  • TABLE 202. ASIA-PACIFIC CANALOPLASTY MARKET SIZE, BY AB INTERNO, 2018-2032 (USD MILLION)
  • TABLE 203. ASIA-PACIFIC CANALOPLASTY MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 204. ASIA-PACIFIC CANALOPLASTY MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, 2018-2032 (USD MILLION)
  • TABLE 205. ASIA-PACIFIC CANALOPLASTY MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
  • TABLE 206. ASIA-PACIFIC CANALOPLASTY MARKET SIZE, BY OPHTHALMOLOGY CLINICS, 2018-2032 (USD MILLION)
  • TABLE 207. ASIA-PACIFIC CANALOPLASTY MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 208. ASIA-PACIFIC CANALOPLASTY MARKET SIZE, BY DISTRIBUTOR SALES, 2018-2032 (USD MILLION)
  • TABLE 209. ASIA-PACIFIC CANALOPLASTY MARKET SIZE, BY INDICATION, 2018-2032 (USD MILLION)
  • TABLE 210. ASIA-PACIFIC CANALOPLASTY MARKET SIZE, BY SECONDARY GLAUCOMA, 2018-2032 (USD MILLION)
  • TABLE 211. ASIA-PACIFIC CANALOPLASTY MARKET SIZE, BY AGE GROUP, 2018-2032 (USD MILLION)
  • TABLE 212. GLOBAL CANALOPLASTY MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 213. ASEAN CANALOPLASTY MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 214. ASEAN CANALOPLASTY MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 215. ASEAN CANALOPLASTY MARKET SIZE, BY VISCOELASTIC AGENTS, 2018-2032 (USD MILLION)
  • TABLE 216. ASEAN CANALOPLASTY MARKET SIZE, BY TECHNIQUE, 2018-2032 (USD MILLION)
  • TABLE 217. ASEAN CANALOPLASTY MARKET SIZE, BY AB INTERNO, 2018-2032 (USD MILLION)
  • TABLE 218. ASEAN CANALOPLASTY MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 219. ASEAN CANALOPLASTY MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, 2018-2032 (USD MILLION)
  • TABLE 220. ASEAN CANALOPLASTY MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
  • TABLE 221. ASEAN CANALOPLASTY MARKET SIZE, BY OPHTHALMOLOGY CLINICS, 2018-2032 (USD MILLION)
  • TABLE 222. ASEAN CANALOPLASTY MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 223. ASEAN CANALOPLASTY MARKET SIZE, BY DISTRIBUTOR SALES, 2018-2032 (USD MILLION)
  • TABLE 224. ASEAN CANALOPLASTY MARKET SIZE, BY INDICATION, 2018-2032 (USD MILLION)
  • TABLE 225. ASEAN CANALOPLASTY MARKET SIZE, BY SECONDARY GLAUCOMA, 2018-2032 (USD MILLION)
  • TABLE 226. ASEAN CANALOPLASTY MARKET SIZE, BY AGE GROUP, 2018-2032 (USD MILLION)
  • TABLE 227. GCC CANALOPLASTY MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 228. GCC CANALOPLASTY MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 229. GCC CANALOPLASTY MARKET SIZE, BY VISCOELASTIC AGENTS, 2018-2032 (USD MILLION)
  • TABLE 230. GCC CANALOPLASTY MARKET SIZE, BY TECHNIQUE, 2018-2032 (USD MILLION)
  • TABLE 231. GCC CANALOPLASTY MARKET SIZE, BY AB INTERNO, 2018-2032 (USD MILLION)
  • TABLE 232. GCC CANALOPLASTY MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 233. GCC CANALOPLASTY MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, 2018-2032 (USD MILLION)
  • TABLE 234. GCC CANALOPLASTY MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
  • TABLE 235. GCC CANALOPLASTY MARKET SIZE, BY OPHTHALMOLOGY CLINICS, 2018-2032 (USD MILLION)
  • TABLE 236. GCC CANALOPLASTY MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 237. GCC CANALOPLASTY MARKET SIZE, BY DISTRIBUTOR SALES, 2018-2032 (USD MILLION)
  • TABLE 238. GCC CANALOPLASTY MARKET SIZE, BY INDICATION, 2018-2032 (USD MILLION)
  • TABLE 239. GCC CANALOPLASTY MARKET SIZE, BY SECONDARY GLAUCOMA, 2018-2032 (USD MILLION)
  • TABLE 240. GCC CANALOPLASTY MARKET SIZE, BY AGE GROUP, 2018-2032 (USD MILLION)
  • TABLE 241. EUROPEAN UNION CANALOPLASTY MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 242. EUROPEAN UNION CANALOPLASTY MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 243. EUROPEAN UNION CANALOPLASTY MARKET SIZE, BY VISCOELASTIC AGENTS, 2018-2032 (USD MILLION)
  • TABLE 244. EUROPEAN UNION CANALOPLASTY MARKET SIZE, BY TECHNIQUE, 2018-2032 (USD MILLION)
  • TABLE 245. EUROPEAN UNION CANALOPLASTY MARKET SIZE, BY AB INTERNO, 2018-2032 (USD MILLION)
  • TABLE 246. EUROPEAN UNION CANALOPLASTY MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 247. EUROPEAN UNION CANALOPLASTY MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, 2018-2032 (USD MILLION)
  • TABLE 248. EUROPEAN UNION CANALOPLASTY MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
  • TABLE 249. EUROPEAN UNION CANALOPLASTY MARKET SIZE, BY OPHTHALMOLOGY CLINICS, 2018-2032 (USD MILLION)
  • TABLE 250. EUROPEAN UNION CANALOPLASTY MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 251. EUROPEAN UNION CANALOPLASTY MARKET SIZE, BY DISTRIBUTOR SALES, 2018-2032 (USD MILLION)
  • TABLE 252. EUROPEAN UNION CANALOPLASTY MARKET SIZE, BY INDICATION, 2018-2032 (USD MILLION)
  • TABLE 253. EUROPEAN UNION CANALOPLASTY MARKET SIZE, BY SECONDARY GLAUCOMA, 2018-2032 (USD MILLION)
  • TABLE 254. EUROPEAN UNION CANALOPLASTY MARKET SIZE, BY AGE GROUP, 2018-2032 (USD MILLION)
  • TABLE 255. BRICS CANALOPLASTY MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 256. BRICS CANALOPLASTY MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 257. BRICS CANALOPLASTY MARKET SIZE, BY VISCOELASTIC AGENTS, 2018-2032 (USD MILLION)
  • TABLE 258. BRICS CANALOPLASTY MARKET SIZE, BY TECHNIQUE, 2018-2032 (USD MILLION)
  • TABLE 259. BRICS CANALOPLASTY MARKET SIZE, BY AB INTERNO, 2018-2032 (USD MILLION)
  • TABLE 260. BRICS CANALOPLASTY MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 261. BRICS CANALOPLASTY MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, 2018-2032 (USD MILLION)
  • TABLE 262. BRICS CANALOPLASTY MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
  • TABLE 263. BRICS CANALOPLASTY MARKET SIZE, BY OPHTHALMOLOGY CLINICS, 2018-2032 (USD MILLION)
  • TABLE 264. BRICS CANALOPLASTY MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 265. BRICS CANALOPLASTY MARKET SIZE, BY DISTRIBUTOR SALES, 2018-2032 (USD MILLION)
  • TABLE 266. BRICS CANALOPLASTY MARKET SIZE, BY INDICATION, 2018-2032 (USD MILLION)
  • TABLE 267. BRICS CANALOPLASTY MARKET SIZE, BY SECONDARY GLAUCOMA, 2018-2032 (USD MILLION)
  • TABLE 268. BRICS CANALOPLASTY MARKET SIZE, BY AGE GROUP, 2018-2032 (USD MILLION)
  • TABLE 269. G7 CANALOPLASTY MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 270. G7 CANALOPLASTY MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 271. G7 CANALOPLASTY MARKET SIZE, BY VISCOELASTIC AGENTS, 2018-2032 (USD MILLION)
  • TABLE 272. G7 CANALOPLASTY MARKET SIZE, BY TECHNIQUE, 2018-2032 (USD MILLION)
  • TABLE 273. G7 CANALOPLASTY MARKET SIZE, BY AB INTERNO, 2018-2032 (USD MILLION)
  • TABLE 274. G7 CANALOPLASTY MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 275. G7 CANALOPLASTY MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, 2018-2032 (USD MILLION)
  • TABLE 276. G7 CANALOPLASTY MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
  • TABLE 277. G7 CANALOPLASTY MARKET SIZE, BY OPHTHALMOLOGY CLINICS, 2018-2032 (USD MILLION)
  • TABLE 278. G7 CANALOPLASTY MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 279. G7 CANALOPLASTY MARKET SIZE, BY DISTRIBUTOR SALES, 2018-2032 (USD MILLION)
  • TABLE 280. G7 CANALOPLASTY MARKET SIZE, BY INDICATION, 2018-2032 (USD MILLION)
  • TABLE 281. G7 CANALOPLASTY MARKET SIZE, BY SECONDARY GLAUCOMA, 2018-2032 (USD MILLION)
  • TABLE 282. G7 CANALOPLASTY MARKET SIZE, BY AGE GROUP, 2018-2032 (USD MILLION)
  • TABLE 283. NATO CANALOPLASTY MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 284. NATO CANALOPLASTY MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 285. NATO CANALOPLASTY MARKET SIZE, BY VISCOELASTIC AGENTS, 2018-2032 (USD MILLION)
  • TABLE 286. NATO CANALOPLASTY MARKET SIZE, BY TECHNIQUE, 2018-2032 (USD MILLION)
  • TABLE 287. NATO CANALOPLASTY MARKET SIZE, BY AB INTERNO, 2018-2032 (USD MILLION)
  • TABLE 288. NATO CANALOPLASTY MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 289. NATO CANALOPLASTY MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, 2018-2032 (USD MILLION)
  • TABLE 290. NATO CANALOPLASTY MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
  • TABLE 291. NATO CANALOPLASTY MARKET SIZE, BY OPHTHALMOLOGY CLINICS, 2018-2032 (USD MILLION)
  • TABLE 292. NATO CANALOPLASTY MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 293. NATO CANALOPLASTY MARKET SIZE, BY DISTRIBUTOR SALES, 2018-2032 (USD MILLION)
  • TABLE 294. NATO CANALOPLASTY MARKET SIZE, BY INDICATION, 2018-2032 (USD MILLION)
  • TABLE 295. NATO CANALOPLASTY MARKET SIZE, BY SECONDARY GLAUCOMA, 2018-2032 (USD MILLION)
  • TABLE 296. NATO CANALOPLASTY MARKET SIZE, BY AGE GROUP, 2018-2032 (USD MILLION)
  • TABLE 297. GLOBAL CANALOPLASTY MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 298. UNITED STATES CANALOPLASTY MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 299. UNITED STATES CANALOPLASTY MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 300. UNITED STATES CANALOPLASTY MARKET SIZE, BY VISCOELASTIC AGENTS, 2018-2032 (USD MILLION)
  • TABLE 301. UNITED STATES CANALOPLASTY MARKET SIZE, BY TECHNIQUE, 2018-2032 (USD MILLION)
  • TABLE 302. UNITED STATES CANALOPLASTY MARKET SIZE, BY AB INTERNO, 2018-2032 (USD MILLION)
  • TABLE 303. UNITED STATES CANALOPLASTY MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 304. UNITED STATES CANALOPLASTY MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, 2018-2032 (USD MILLION)
  • TABLE 305. UNITED STATES CANALOPLASTY MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
  • TABLE 306. UNITED STATES CANALOPLASTY MARKET SIZE, BY OPHTHALMOLOGY CLINICS, 2018-2032 (USD MILLION)
  • TABLE 307. UNITED STATES CANALOPLASTY MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 308. UNITED STATES CANALOPLASTY MARKET SIZE, BY DISTRIBUTOR SALES, 2018-2032 (USD MILLION)
  • TABLE 309. UNITED STATES CANALOPLASTY MARKET SIZE, BY INDICATION, 2018-2032 (USD MILLION)
  • TABLE 310. UNITED STATES CANALOPLASTY MARKET SIZE, BY SECONDARY GLAUCOMA, 2018-2032 (USD MILLION)
  • TABLE 311. UNITED STATES CANALOPLASTY MARKET SIZE, BY AGE GROUP, 2018-2032 (USD MILLION)
  • TABLE 312. CHINA CANALOPLASTY MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 313. CHINA CANALOPLASTY MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 314. CHINA CANALOPLASTY MARKET SIZE, BY VISCOELASTIC AGENTS, 2018-2032 (USD MILLION)
  • TABLE 315. CHINA CANALOPLASTY MARKET SIZE, BY TECHNIQUE, 2018-2032 (USD MILLION)
  • TABLE 316. CHINA CANALOPLASTY MARKET SIZE, BY AB INTERNO, 2018-2032 (USD MILLION)
  • TABLE 317. CHINA CANALOPLASTY MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 318. CHINA CANALOPLASTY MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, 2018-2032 (USD MILLION)
  • TABLE 319. CHINA CANALOPLASTY MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
  • TABLE 320. CHINA CANALOPLASTY MARKET SIZE, BY OPHTHALMOLOGY CLINICS, 2018-2032 (USD MILLION)
  • TABLE 321. CHINA CANALOPLASTY MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 322. CHINA CANALOPLASTY MARKET SIZE, BY DISTRIBUTOR SALES, 2018-2032 (USD MILLION)
  • TABLE 323. CHINA CANALOPLASTY MARKET SIZE, BY INDICATION, 2018-2032 (USD MILLION)
  • TABLE 324. CHINA CANALOPLASTY MARKET SIZE, BY SECONDARY GLAUCOMA, 2018-2032 (USD MILLION)
  • TABLE 325. CHINA CANALOPLASTY MARKET SIZE, BY AGE GROUP, 2018-2032 (USD MILLION)